The p202 Gene as a Tumor Suppressor in Prostate Cancer Cells

Abstract

During the funding period, we have completed the most Aims and subaims proposed in the proposal, i.e. to determine the anti-tumor and the proapoptotic activities of p202 in prostate cancer cells; to understand the molecular mechanisms underlying the p2O2-mediated anti-growth, anti-tumor, and potential proapoptosis activities in prostate cancer; and to test the anti-tumor activity of p202 in prostate cancer cells using preclincal gene therapy strategies and to determine the efficacy of a combined treatment with TN F-a in an orthotopic prostate cancer model. In an attempt to initiate a p202 clinical trial, we have communicated with the FDA and been informed that the human gene is preferable over murine one. Therefore, we have proceeded to clone a human counterpart of p202 gene, the AIM2 Labsent in melanoma). We have obtained encouraging results on AIM2 that has the similar effect of p202 in anti-growth activity in prostate cancer cells in cell culture, and exhibits an anti-tumor growth activity in animals bearing mammary tumors. To further extend the specificity for both androgen receptor-positive and -refractory prostate cancers, we have newly developed a broad spectrum of prostate cancer-specific promoter. We intend to test the therapeutic efficacy and specificity by using the broad spectrum of prostate cancer-specific promoter to drive the therapeutic gene, AIM2 in animals. In an attempt to discover more novel strategies to treat prostate cancer, we have found a natural compound, emodin, which has shown a promising killing effect on prostate cancer cells. To further pursue the potential application of AI2 gene for parastate cancer in a gene therapy setting, we have submitted a grant proposal entitled The AIM 2 Gene as a Tumor Suppressor in Prostate Cancer Cells" for the IDEA Award to the Department of Defense on February 10, 2004 deadline.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jun 01, 2004
Accession Number
ADA428674

Entities

People

  • Mien-Chie Hung

Organizations

  • University of Texas at Austin

Tags

DTIC Thesaurus Topics

  • Antineoplastic Agents
  • Cell Physiological Processes
  • Cells
  • Chemical Synthesis
  • Chemistry
  • Gene Therapy
  • Health Services
  • Medical Personnel
  • Oncology
  • Proteins

Fields of Study

  • Biology
  • Medicine

Readers

  • Clinical Trial Research.
  • Oncology (Cancer Research).

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech